2020 - Second $120,000 CVHLA and CRS Research Grant Announced!
Fundraising led by the Rick Bracey Memorial baseball tournament in Surrey BC and the Ontario Walk and Dance fundraising and the countless individual donations from across the country have allowed the CVHLA to put up a second $60,000 spread over 2020 and 2021 for Canadian Cancer Research. Our partner, the Cancer Research Society (CRS), has matched this with their own $60,000.
This is the second CRS partnership! in 2018 the CVHLA and CRS partnership identified Dr. Najafabadi's McGill research as an excellent fit for the CVHLA money.
Due to the strength of the VHL grant applications, in 2018 the CRS also funded another VHL related research grant in Toronto for $120,000.
Your $120,000 raised turned into $360,000 for VHL research here in Canada!!
Thank you for your support!
Canadian VHL Alliance (CVHLA) Research Funding
Since 2018 we have created $240,000 in Canadian VHL research grants with our partner the Cancer Research Society!
2020 - $120,000 Research Grant Partnership
In November of 2019 the Canadian VHL Alliance (CVHLA) has entered into a second partnership with The Cancer Research Society (CRS), a Canadian based organization that will match the $60,000 CVHLA donation, to create a $120,000 grant that will be awarded in 2020.
2018 - $120,000 Research Grant Partnership
The first partnership between the CVHLA and the CRS in 2018 created a grant that was won by Dr. Najafabadi (see above for details)
In 2017 the Cancer Research Society has funded the following projects that are related to the VHL gene and/or ccRCC:
Dr. Ryan Russell, University of Ottawa: Characterization of VHL-mediated RB regulation in renal cancer
Dr. Stefan Taubert, The University of British Columbia (UBC): Exploring Mediator-dependent stress resistance as a new target (a protein acting downstream of VHL, in the same molecular pathway)
Dr. Yasser Riazalhosseini, McGill University: KDM5C mutations as determinants of sex-dependent therapy in renal cell carcinoma
Dr. Damu Tang, McMaster University: Characterization of CYB5D2-mediated suppression of clear cell renal cell carcinoma (ccRCC)
Three grants on VHL were funded by the Cancer Research Society in the past years:
Sandra Turcotte, U of Moncton (2012-2014): The late-stage of autophagy: A role for the tumor suppressor gene von Hippel-Lindau in lysosomal degradation
Amin Pause, McGill University (2006-2008): The von Hippel-Lindau (VHL) protein suppresses angiogenesis by maintaining extracellular matrix integrity
Stephen Lee, University of Ottawa (2004-2006): Dissecting the oncogenic pathway of VHL loss kidney cancer
Our CVHLA goal is to apply a very large percentage of our donations directly to funding Research Projects.
The video below describes a research project the US based VHL Alliance has funded. The CVHLA has supported these efforts in the past.